Literature DB >> 28619453

Poly(ethylene oxide)/hydroxypropyl-β-cyclodextrin films for oromucosal delivery of hydrophilic drugs.

Ivana d'Angelo1, Aurore Fraix2, Francesca Ungaro3, Fabiana Quaglia3, Agnese Miro4.   

Abstract

In this study, we highlight the potential of the mucoadhesive film made from a poly(ethylene oxide)/hydroxypropyl-β-cyclodextrin (PEO/CD) mixture in the oromucosal delivery of hydrophilic drugs, with a specific focus on dexamethasone phosphate disodium salt (Dexa). CD formed a complex with Dexa in solution and did not interact with mucin as highlighted from the spectrophotometric and spectrofluorimetric analysis. Similarly, CD and PEO did not affect mucin conformation, suggesting no direct interaction between the unstirred water layer and film components. Remarkably, PEO/CD/Dexa films dissolved more slowly than those made of PEO alone also in phosphate-buffered saline (PBS) pH 6.8 and gave a time-control on Dexa delivered dose. These combined effects resulted in a higher amount of Dexa accumulated in the mucosa, which can be highly beneficial in case of local diseases. Furthermore, Dexa amount able to diffuse through porcine buccal mucosa was lower when film contained CD, highlighting how CD can act as a modulator of drug transport also in the case of water-soluble drugs. In summary, our results demonstrate the versatility of PEO/CD films in mucosal delivery of hydrophilic corticosteroids paving the way to a novel approach in the treatment of mouth diseases.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cyclodextrins; Mucin; Mucoadhesive film; Oromucosal delivery; Poly(ethylene oxide)

Mesh:

Substances:

Year:  2017        PMID: 28619453     DOI: 10.1016/j.ijpharm.2017.06.029

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  1 in total

Review 1.  Stimuli-Responsive Polymers for Transdermal, Transmucosal and Ocular Drug Delivery.

Authors:  Dmitriy Berillo; Zharylkasyn Zharkinbekov; Yevgeniy Kim; Kamila Raziyeva; Kamila Temirkhanova; Arman Saparov
Journal:  Pharmaceutics       Date:  2021-12-01       Impact factor: 6.321

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.